雅居樂(03383.HK)溢價20%發行雅生活(03319.HK)可換股債券 淨籌23.7億元再融資
雅居樂(03383.HK)公佈,全資附屬公司遠航金門發行本金總額24.18億元之可換股債券,相關可換股債券最多可轉換成8,799.13萬股雅生活(03319.HK)H股股份,相當於後者債券獲悉數交換後已發行股本6.2%。每股交換價27.48元,較協議訂立日期、即昨日(17日)雅生活股份收市價22.9元溢價20%。
公告指,遠航金門透過是次發行所得款項淨額爲23.7億元,將用作於一年內到期的若幹現有中長期離岸債務再融資。假設股份獲悉數交換且無發行新雅生活股份,預期雅居樂集團仍持有雅生活已發行股本總額約48%,雅生活仍爲雅居樂集團附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.